Description: 

• A specialized allopathic tablet that widens blood vessels and improves blood flow to reduce cramp-like muscle pain, tightness, and numbness in the legs during movement. 

Prescription:

•  Prescription Only Medicine (POM). 

Therapeutic Category:

•  Peripheral Vasodilator / Platelet Aggregation Inhibitor (Phosphodiesterase III Inhibitor). 

Active Ingredients/Composition: 

• Each tablet contains 100 mg of Cilostazol formulated to Indian Pharmacopoeia (I.P.) standards.

Variant: 

• 100mg immediate-release tablet (also commonly available globally in 50mg strengths). 

Consume Type:

•  Oral use only (swallowed whole with a glass of water). 

Directions/Usage:

• The standard adult dose is typically one 100mg tablet taken twice daily.
• Administration Requirement: Must be taken on an empty stomach, at least 30 minutes before or 2 hours after breakfast and dinner. Grapefruit juice must be avoided during treatment as it alters drug absorption.
• Timeline: Initial benefits may appear within 2 to 4 weeks, but up to 12 weeks of consistent use may be required to achieve full clinical efficacy. 

Common Side Effects: Headache (most common), diarrhea, abnormal stool, palpitations (fast or irregular heartbeat), chest pain, dizziness, and peripheral edema (fluid retention/swelling in the ankles or feet). 

Package Type: 

• Offered in blister strips, typically boxed as a 10 x 10 tablet pack (100 tablets total per retail carton). 

• Storage Advice:
•  Store in a cool, dry place below 30°C. Protect completely from intense heat, moisture, and direct light. Keep safely away from children. 

Safety Advice:

• Black Box Warning / Absolute Contraindication: Cilostazol is strictly contraindicated in patients with Congestive Heart Failure (CHF) of any severity, as similar phosphodiesterase inhibitors increase the absolute risk of mortality in these patients.
• Do not use if you have an active bleeding disorder (such as a bleeding stomach ulcer or intracranial bleeding).
• A dose reduction to 50mg twice daily may be medically required if co-administered with strong CYP3A4 or CYP2C19 inhibitors like omeprazole, erythromycin, or ketoconazole.

Manufacturer/Marketer: 

• Manufactured and marketed by Healing Pharma 

Country of Origin: 

• India.